1. Home
  2. LRFC vs MURA Comparison

LRFC vs MURA Comparison

Compare LRFC & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRFC
  • MURA
  • Stock Information
  • Founded
  • LRFC 2013
  • MURA 2013
  • Country
  • LRFC United States
  • MURA Ireland
  • Employees
  • LRFC N/A
  • MURA N/A
  • Industry
  • LRFC Finance: Consumer Services
  • MURA
  • Sector
  • LRFC Finance
  • MURA
  • Exchange
  • LRFC Nasdaq
  • MURA Nasdaq
  • Market Cap
  • LRFC 47.6M
  • MURA 45.8M
  • IPO Year
  • LRFC 2013
  • MURA N/A
  • Fundamental
  • Price
  • LRFC $17.05
  • MURA $2.57
  • Analyst Decision
  • LRFC
  • MURA Strong Buy
  • Analyst Count
  • LRFC 0
  • MURA 4
  • Target Price
  • LRFC N/A
  • MURA $13.00
  • AVG Volume (30 Days)
  • LRFC 9.2K
  • MURA 154.1K
  • Earning Date
  • LRFC 05-08-2025
  • MURA 05-14-2025
  • Dividend Yield
  • LRFC 8.45%
  • MURA N/A
  • EPS Growth
  • LRFC N/A
  • MURA N/A
  • EPS
  • LRFC N/A
  • MURA N/A
  • Revenue
  • LRFC $20,544,000.00
  • MURA N/A
  • Revenue This Year
  • LRFC N/A
  • MURA $34.35
  • Revenue Next Year
  • LRFC N/A
  • MURA N/A
  • P/E Ratio
  • LRFC N/A
  • MURA N/A
  • Revenue Growth
  • LRFC 3.11
  • MURA N/A
  • 52 Week Low
  • LRFC $16.57
  • MURA $0.95
  • 52 Week High
  • LRFC $26.00
  • MURA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • LRFC 33.20
  • MURA 47.97
  • Support Level
  • LRFC $17.60
  • MURA $2.56
  • Resistance Level
  • LRFC $18.04
  • MURA $2.69
  • Average True Range (ATR)
  • LRFC 0.43
  • MURA 0.14
  • MACD
  • LRFC 0.02
  • MURA -0.03
  • Stochastic Oscillator
  • LRFC 26.37
  • MURA 16.33

About LRFC Logan Ridge Finance Corporation

Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: